Two Sigma Investments
BEAM icon

Two Sigma Investments’s Beam Therapeutics BEAM Stock Holding History

Two Sigma Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.9M Buy
1,210,853
+90,464
+8% +$2.51M 0.02% 745
2025
Q4 		$31.1M Buy
1,120,389
+741,345
+196% +$18.9M 0.04% 526
2025
Q3 		$9.2M Sell
379,044
-182,477
-32% -$3.63M 0.01% 1009
2025
Q2 		$9.55M Buy
561,521
+192,320
+52% +$3.35M 0.02% 850
2025
Q1 		$7.21M Buy
369,201
+252,113
+215% +$6.6M 0.02% 930
2024
Q4 		$2.9M Buy
117,088
+50,271
+75% +$1.28M 0.01% 1465
2024
Q3 		$1.64M Sell
66,817
-53,948
-45% -$1.39M ﹤0.01% 1797
2024
Q2 		$2.83M Sell
120,765
-238,033
-66% -$5.85M 0.01% 1320
2024
Q1 		$11.9M Buy
+358,798
New +$11.2M 0.03% 598
2023
Q3 		– Sell
-7,400
Closed -$236K – 2958
2023
Q2 		$236K Sell
7,400
-53,900
-88% -$1.75M ﹤0.01% 2594
2023
Q1 		$1.88M Buy
+61,300
New +$2.42M 0.01% 1415
2022
Q4 		– Sell
-198,996
Closed -$9.48M – 2806
2022
Q3 		$9.48M Buy
198,996
+161,878
+436% +$9.23M 0.03% 510
2022
Q2 		$1.44M Sell
37,118
-32,462
-47% -$1.29M ﹤0.01% 1369
2022
Q1 		$3.99M Buy
69,580
+45,214
+186% +$2.97M 0.01% 1022
2021
Q4 		$1.94M Sell
24,366
-191,331
-89% -$16.4M ﹤0.01% 1939
2021
Q3 		$18.8M Buy
215,697
+48,096
+29% +$4.83M 0.04% 494
2021
Q2 		$21.6M Buy
167,601
+133,525
+392% +$10.6M 0.05% 462
2021
Q1 		$2.73M Buy
+34,076
New +$3.24M 0.01% 1468

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Two Sigma Investments's BEAM Position: Q1 2026 in Review

Two Sigma Investments increased its Beam Therapeutics (BEAM) stake by 8.1% in Q1 2026, buying an estimated $2.51M and bringing the position to 1,210,853 shares worth $28.9M. The position accounts for 0.02% of the portfolio, ranked #745.

Two Sigma Investments first reported a position in BEAM in Q1 2021 and has held it in 18 quarters since. The position peaked at $31.1M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Two Sigma Investments held 1,210,853 shares of Beam Therapeutics worth $28.9M as of Q1 2026.
  • Two Sigma Investments bought 90,464 Beam Therapeutics shares in Q1 2026, an estimated $2.51M.
  • Beam Therapeutics made up 0.02% of Two Sigma Investments's portfolio in Q1 2026, its #745 holding.
  • Two Sigma Investments first reported a position in Beam Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Two Sigma Investments's Beam Therapeutics position peaked at $31.1M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.